NCT05701085 Patient Navigator PRE-ACT Educational Intervention to Promote Decision Making Among Minorities
| NCT ID | NCT05701085 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Case Comprehensive Cancer Center |
| Condition | Educational Intervention |
| Study Type | INTERVENTIONAL |
| Enrollment | 240 participants |
| Start Date | 2023-04-24 |
| Primary Completion | 2026-10-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 240 participants in total. It began in 2023-04-24 with a primary completion date of 2026-10-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study focuses on psychosocial barriers at the patient level with the goal of promoting high quality decision making around clinical trials participation. The proposed study adapts the PRE-ACT model to racial and ethnic minority patients who were underrepresented in the original PRE-ACT study and will be combined with a patient navigator model.
Eligibility Criteria
Inclusion Criteria: * Participants must have a diagnosis of either advanced (metastatic) cancer or early stage disease for which they are undergoing oncological work-up, treatment or surveillance * Participants must be at least 18 years of age * Participants have a non-white race or Hispanic ethnicity recorded in their patient demographics in the electronic medical record * Participant must have a life expectancy greater than three months based on the primary oncology team's clinical assessment. * Participants must be able to read and verbally communicate in English. * Participants must provide written informed consent. Exclusion Criteria: \-
Contact & Investigator
Lauren Chiec, MD
PRINCIPAL INVESTIGATOR
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center
Frequently Asked Questions
Who can join the NCT05701085 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Educational Intervention. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05701085 currently recruiting?
Yes, NCT05701085 is actively recruiting participants. Contact the research team at lauren.chiec@uhhospitals.org for enrollment information.
Where is the NCT05701085 trial being conducted?
This trial is being conducted at Cleveland, United States.
Who is sponsoring the NCT05701085 clinical trial?
NCT05701085 is sponsored by Case Comprehensive Cancer Center. The principal investigator is Lauren Chiec, MD at University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center. The trial plans to enroll 240 participants.